Hermsen, E. D., Hovde, L. B., Sprandel, K. A., Rodvold, K. A., & Rotschafer, J. C. (2005). Levofloxacin plus Metronidazole Administered Once Daily versus Moxifloxacin Monotherapy against a Mixed Infection of Escherichia coli and Bacteroides fragilis in an In Vitro Pharmacodynamic Model. American Society for Microbiology.

Hermsen, Elizabeth D., Laurie B. Hovde, Kelly A. Sprandel, Keith A. Rodvold, und John C. Rotschafer. Levofloxacin Plus Metronidazole Administered Once Daily Versus Moxifloxacin Monotherapy against a Mixed Infection of Escherichia Coli and Bacteroides Fragilis in an In Vitro Pharmacodynamic Model. American Society for Microbiology, 2005.

Hermsen, Elizabeth D., et al. Levofloxacin Plus Metronidazole Administered Once Daily Versus Moxifloxacin Monotherapy against a Mixed Infection of Escherichia Coli and Bacteroides Fragilis in an In Vitro Pharmacodynamic Model. American Society for Microbiology, 2005.